Back to Search
Start Over
Cognitive Profile and Mental Health in Adult Phenylketonuria
- Source :
- Neuropsychology, 31(4), 437-447. American Psychological Association Inc., Neuropsychology, 31, 4, pp. 437-447, Neuropsychology, 31(4), 437-447. American Psychological Association, Neuropsychology, 31(4), 437. American Psychological Association Inc., Neuropsychology, 31(4), 437-447. AMER PSYCHOLOGICAL ASSOC, Neuropsychology, 31, 437-447
- Publication Year :
- 2017
-
Abstract
- Item does not contain fulltext OBJECTIVE: Despite early dietary treatment phenylketonuria patients have lower IQ and poorer executive functions compared to healthy controls. Cognitive problems in phenylketonuria have often been associated with phenylalanine levels. The present study examined the cognitive profile and mental health in adult phenylketonuria, in relation to phenylalanine levels and tetrahydrobiopterin treatment. METHOD: Fifty-seven early treated adult patients with phenylketonuria and 57 healthy matched controls (18-40 years) performed IQ subtests and executive function tests from the Amsterdam Neuropsychological Tasks. They also completed the Adult Self-Report on mental health problems. Analyses of variance were performed to examine group differences. RESULTS: Patients with phenylketonuria had normal IQs although lower than controls. They performed poorer on working memory, inhibitory control, and sustained attention tasks. Patients reported Depressive and Avoidant Personality problems more frequently. Specifically, patients with childhood and lifetime phenylalanine >/=360 mumol/L had poorer cognitive and mental health outcomes than controls. In a subset of patients, comparisons between patients on and off tetrahydrobiopterin showed that nontetrahydrobiopterin users (matched for childhood, pretreatment phenylalanine) were slower (on number of tasks) and reported more mental health problems. CONCLUSIONS: Adult patients had lower IQ and poorer executive functions than controls, resembling problems observed in younger patients with phenylketonuria, as well as more internalizing problems. Group differences and phenylalanine-outcome associations were smaller than those observed in younger populations. A subset of nontetrahydrobiopterin users, matched for childhood phenylalanine level, had a poorer outcome on some tests than tetrahydrobiopterin users, which might indicate an impact of tetrahydrobiopterin treatment beyond lowering phenylalanine. However, clinical relevance needs further investigation. (PsycINFO Database Record
- Subjects :
- 0301 basic medicine
Male
Inhibition (Psychology)
Phenylketonurias
Health Status
BLOOD PHENYLALANINE LEVELS
CHILDREN
030105 genetics & heredity
Executive Function
0302 clinical medicine
Cognition
ADOLESCENTS
adults
Attention
Young adult
Intelligence Tests
Intelligence quotient
Depression
Neuropsychology
Metabolic Disorders Radboud Institute for Molecular Life Sciences [Radboudumc 6]
Executive functions
executive functions
Metabolism disorder
Inhibition, Psychological
Neuropsychology and Physiological Psychology
Memory, Short-Term
Mental Health
tetrahydrobiopterin
Female
SAPROPTERIN
Psychology
mental health
Clinical psychology
Adult
Adolescent
Phenylalanine
phenylketonuria
INHIBITION
Personality Disorders
03 medical and health sciences
Young Adult
SDG 3 - Good Health and Well-being
TETRAHYDROBIOPTERIN BH4
Memory
Journal Article
Humans
METAANALYSIS
EXECUTIVE FUNCTION IMPAIRMENT
EARLY-TREATED PHENYLKETONURIA
Mental health
Biopterin
INDIVIDUALS
Short-Term
Self Report
030217 neurology & neurosurgery
Subjects
Details
- Language :
- English
- ISSN :
- 08944105
- Volume :
- 31
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- Neuropsychology
- Accession number :
- edsair.doi.dedup.....9d533cfac5fa9bbc67eae709e647f48b
- Full Text :
- https://doi.org/10.1037/neu0000358